Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.
Saved in:
| Title: | Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models. |
|---|---|
| Authors: | O'Donnell CJ; Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, USA. christopher.j.odonnell@pfizer.com, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L |
| Source: | Journal of medicinal chemistry [J Med Chem] 2010 Feb 11; Vol. 53 (3), pp. 1222-37. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20043678 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22O'Donnell+CJ%22">O'Donnell CJ</searchLink>; Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, USA. christopher.j.odonnell@pfizer.com<br /><searchLink fieldCode="AU" term="%22Rogers+BN%22">Rogers BN</searchLink><br /><searchLink fieldCode="AU" term="%22Bronk+BS%22">Bronk BS</searchLink><br /><searchLink fieldCode="AU" term="%22Bryce+DK%22">Bryce DK</searchLink><br /><searchLink fieldCode="AU" term="%22Coe+JW%22">Coe JW</searchLink><br /><searchLink fieldCode="AU" term="%22Cook+KK%22">Cook KK</searchLink><br /><searchLink fieldCode="AU" term="%22Duplantier+AJ%22">Duplantier AJ</searchLink><br /><searchLink fieldCode="AU" term="%22Evrard+E%22">Evrard E</searchLink><br /><searchLink fieldCode="AU" term="%22Hajós+M%22">Hajós M</searchLink><br /><searchLink fieldCode="AU" term="%22Hoffmann+WE%22">Hoffmann WE</searchLink><br /><searchLink fieldCode="AU" term="%22Hurst+RS%22">Hurst RS</searchLink><br /><searchLink fieldCode="AU" term="%22Maklad+N%22">Maklad N</searchLink><br /><searchLink fieldCode="AU" term="%22Mather+RJ%22">Mather RJ</searchLink><br /><searchLink fieldCode="AU" term="%22McLean+S%22">McLean S</searchLink><br /><searchLink fieldCode="AU" term="%22Nedza+FM%22">Nedza FM</searchLink><br /><searchLink fieldCode="AU" term="%22O'Neill+BT%22">O'Neill BT</searchLink><br /><searchLink fieldCode="AU" term="%22Peng+L%22">Peng L</searchLink><br /><searchLink fieldCode="AU" term="%22Qian+W%22">Qian W</searchLink><br /><searchLink fieldCode="AU" term="%22Rottas+MM%22">Rottas MM</searchLink><br /><searchLink fieldCode="AU" term="%22Sands+SB%22">Sands SB</searchLink><br /><searchLink fieldCode="AU" term="%22Schmidt+AW%22">Schmidt AW</searchLink><br /><searchLink fieldCode="AU" term="%22Shrikhande+AV%22">Shrikhande AV</searchLink><br /><searchLink fieldCode="AU" term="%22Spracklin+DK%22">Spracklin DK</searchLink><br /><searchLink fieldCode="AU" term="%22Wong+DF%22">Wong DF</searchLink><br /><searchLink fieldCode="AU" term="%22Zhang+A%22">Zhang A</searchLink><br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2010 Feb 11; Vol. 53 (3), pp. 1222-37. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20043678 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/jm9015075 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1222 Titles: – TitleFull: Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: O'Donnell CJ – PersonEntity: Name: NameFull: Rogers BN – PersonEntity: Name: NameFull: Bronk BS – PersonEntity: Name: NameFull: Bryce DK – PersonEntity: Name: NameFull: Coe JW – PersonEntity: Name: NameFull: Cook KK – PersonEntity: Name: NameFull: Duplantier AJ – PersonEntity: Name: NameFull: Evrard E – PersonEntity: Name: NameFull: Hajós M – PersonEntity: Name: NameFull: Hoffmann WE – PersonEntity: Name: NameFull: Hurst RS – PersonEntity: Name: NameFull: Maklad N – PersonEntity: Name: NameFull: Mather RJ – PersonEntity: Name: NameFull: McLean S – PersonEntity: Name: NameFull: Nedza FM – PersonEntity: Name: NameFull: O'Neill BT – PersonEntity: Name: NameFull: Peng L – PersonEntity: Name: NameFull: Qian W – PersonEntity: Name: NameFull: Rottas MM – PersonEntity: Name: NameFull: Sands SB – PersonEntity: Name: NameFull: Schmidt AW – PersonEntity: Name: NameFull: Shrikhande AV – PersonEntity: Name: NameFull: Spracklin DK – PersonEntity: Name: NameFull: Wong DF – PersonEntity: Name: NameFull: Zhang A – PersonEntity: Name: NameFull: Zhang L IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 02 Text: 2010 Feb 11 Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1520-4804 Numbering: – Type: volume Value: 53 – Type: issue Value: 3 Titles: – TitleFull: Journal of medicinal chemistry Type: main |
| ResultId | 1 |